Nuclear FGFR1 could control the oncogenic networks involved in organ development, tissue and cell pluripotency, cell cycle, cancer related TP53 pathway, neuroectodermal and mesodermal programming networks, axonal growth and synaptic plasticity pathways [190]. This evidence concerns the gene FGFR1 and cancer.